Invention Grant
- Patent Title: Fusion proteins comprising an anti-CD40 antibody and cancer antigens
-
Application No.: US15703685Application Date: 2017-09-13
-
Publication No.: US10980869B2Publication Date: 2021-04-20
- Inventor: Gerard Zurawski , Jacques F. Banchereau , Anne-Laure Flamar , Peter Klucar , Keiko Akagawa , Sandra Zurawski , SangKon Oh
- Applicant: BAYLOR RESEARCH INSTITUTE
- Applicant Address: US TX Dallas
- Assignee: BAYLOR RESEARCH INSTITUTE
- Current Assignee: BAYLOR RESEARCH INSTITUTE
- Current Assignee Address: US TX Dallas
- Agency: Norton Rose Fulbright US LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C07K16/28 ; C07K14/435
Abstract:
The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.
Public/Granted literature
- US20180000916A1 ANTIGEN PRESENTING CELL TARGETED CANCER VACCINES Public/Granted day:2018-01-04
Information query
